000101508 001__ 101508
000101508 005__ 20220426091138.0
000101508 0247_ $$2doi$$a10.1002/ijgo.13178
000101508 0248_ $$2sideral$$a118235
000101508 037__ $$aART-2020-118235
000101508 041__ $$aeng
000101508 100__ $$0(orcid)0000-0003-0470-223X$$aGarcía-Claver, A.
000101508 245__ $$aCapillary glucose concentration during oral glucose tolerance test for the diagnosis of gestational diabetes
000101508 260__ $$c2020
000101508 5060_ $$aAccess copy available to the general public$$fUnrestricted
000101508 5203_ $$aObjective: To assess concordance between two point-of-care testing (POCT) devices and the standard laboratory method in screening for gestational diabetes mellitus (GDM) in Huesca.
Methods: Pregnant women who met criteria for an oral glucose tolerance test (OGTT) and attended the laboratory between October 2017 and November 2018 were recruited in this prospective observational study. Glucose was measured in venous (laboratory) and capillary blood (Accu-Chek or Contour Next glucometers). GDM was diagnosed attending to NDDG criteria for venous samples or capillary-specific cut-off. Linear regression, Passing–Bablok, Bland–Altman, and the kappa coefficient were used to study concordance between POCT and laboratory method.
Results: Data from 109 women were analyzed (57 for Accu-Chek, 52 for Contour Next). Statistical analyses showed good agreement between both POCT and laboratory method. There were no statistical differences in fasting glucose measurements between capillary and venous samples and both POCT devices meet the ISO 15197 standard. Accu-Chek showed good agreement (k=0.629) regarding the laboratory method in classifying GDM, with an acceptable inter-evaluator bias of 3.5% (P<0.001).
Conclusion: POCT can be used to obtain fasting values and reduce overall waiting times for patients. Additionally, Accu-Chek can be used to diagnose GDM in remote areas applying specific cut-off values.
000101508 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000101508 590__ $$a3.561$$b2020
000101508 591__ $$aOBSTETRICS & GYNECOLOGY$$b20 / 83 = 0.241$$c2020$$dQ1$$eT1
000101508 592__ $$a0.895$$b2020
000101508 593__ $$aObstetrics and Gynecology$$c2020$$dQ2
000101508 593__ $$aMedicine (miscellaneous)$$c2020$$dQ2
000101508 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000101508 700__ $$aRamos-Corral, R.
000101508 700__ $$aLaviña-Fañanás, C.
000101508 700__ $$aSolans-Blecua, I.
000101508 700__ $$0(orcid)0000-0002-1309-4363$$aPuzo-Foncillas, J.$$uUniversidad de Zaragoza
000101508 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000101508 773__ $$g150, 2 (2020), 234-240$$pInt. j. gynaecol. obstet.$$tInternational Journal of Gynecology and Obstetrics$$x0020-7292
000101508 8564_ $$s362973$$uhttps://zaguan.unizar.es/record/101508/files/texto_completo.pdf$$yPostprint
000101508 8564_ $$s1507977$$uhttps://zaguan.unizar.es/record/101508/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000101508 909CO $$ooai:zaguan.unizar.es:101508$$particulos$$pdriver
000101508 951__ $$a2022-04-26-08:55:22
000101508 980__ $$aARTICLE